YOWE; David Langdon
Patent Applications and Registrations
Patent applications and USPTO patent grants for YOWE; David Langdon.The latest application filed is for "methods of treating fgf21-associated disorders".
- YOWE; David Langdon - Belmont MA
- Yowe; David Langdon - Cambridge MA
| Patent | Date |
|---|---|
| Methods Of Treating Fgf21-associated Disorders App 20220162300 - BOETTCHER; Brian ; et al. | 2022-05-26 |
| Methods of treating FGF21-associated disorders Grant 11,236,159 - Boettcher , et al. February 1, 2 | 2022-02-01 |
| FGF21 Mimetic Antibodies and Uses Thereof App 20210171659 - Cebe; Regis ; et al. | 2021-06-10 |
| FGF21 mimetic antibodies and uses thereof Grant 10,899,844 - Cebe , et al. January 26, 2 | 2021-01-26 |
| Methods Of Treating Fgf21-associated Disorders App 20200087392 - BOETTCHER; Brian ; et al. | 2020-03-19 |
| Fgf21 Mimetic Antibodies And Uses Thereof App 20190040153 - CEBE; Regis ; et al. | 2019-02-07 |
| Pcsk9 Antagonists App 20130315927 - Goldstein; Joshua ; et al. | 2013-11-28 |
| Molecules And Methods For Modulating Proprotein Convertase Subtilisin/kexin Type 9 (pcsk9) App 20100233177 - Yowe; David Langdon ; et al. | 2010-09-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 